The safety and efficacy of quadruple ultra-low-dose combination (quadpill) for hypertension treatment: a meta-analysis of randomized controlled trials

Back

ESC Professional Premium Access

The safety and efficacy of quadruple ultra-low-dose combination (quadpill) for hypertension treatment: a meta-analysis of randomized controlled trials

Session: Drugs and devices in hypertension

Topic: Pharmacotherapy

Speaker: Doctor M. Ibrahim (Flint, US)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Mahmoud Ibrahim

McLaren Flint Hospital, Flint (United States of America)

0 follower

7 more presentations in this session

Efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in essential hypertension

Speaker: Professor J. Wang (Shanghai, CN)

Comparing cardiovascular outcomes and costs of perindopril-, enalapril- or losartan-based antihypertensive regimens in South Africa: real-world medical claims database analysis

Speaker: Professor N. Ntusi (Cape Town, ZA)

Neuroprotective efficacy of combined antihypertensive treatment with the inclusion of nitrendipine in patients with arterial hypertension

Speaker: Associate Professor G. Abdullaeva (Tashkent, UZ)

Effects of blood pressure lowering according to baseline cardiovascular disease: systematic review and meta-analysis of randomized trials

Speaker: Doctor E. Manta (Athens, GR)

Improved health-related quality of life after renal denervation in patients with resistant hypertension: 3-year outcomes in the global symplicity registry

Speaker: Associate Professor F. Mahfoud (Homburg, DE)

Access

Abstract

Slides

Access the full session

Drugs and devices in hypertension

Speakers: Doctor M. Ibrahim, Professor J. Wang, Professor N. Ntusi, Associate Professor G. Abdullaeva, Doctor E. Manta...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

The safety and efficacy of quadruple ultra-low-dose combination (quadpill) for hypertension treatment: a meta-analysis of randomized controlled trials

About the speaker

Doctor Mahmoud Ibrahim

7 more presentations in this session

Efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in essential hypertension

Comparing cardiovascular outcomes and costs of perindopril-, enalapril- or losartan-based antihypertensive regimens in South Africa: real-world medical claims database analysis

Neuroprotective efficacy of combined antihypertensive treatment with the inclusion of nitrendipine in patients with arterial hypertension

Effects of blood pressure lowering according to baseline cardiovascular disease: systematic review and meta-analysis of randomized trials

Improved health-related quality of life after renal denervation in patients with resistant hypertension: 3-year outcomes in the global symplicity registry

Access the full session

Drugs and devices in hypertension

About the event

ESC Congress 2023

ESC 365 is supported by